Resources Blog Why is speed important with HTP recombinant antibody production?

Why is speed important with HTP recombinant antibody production?

Biointron 2024-01-20 Read time: 2 mins

DSC_2205.jpg

High-throughput (HTP) recombinant antibody production is the rapid generation of large numbers of recombinant antibodies. Recombinant antibodies are monoclonal antibodies which can be produced in vitro through synthetic genes and antibody fragments, instead of using hybridomas. Here are a few reasons why speed is important:

1. Accelerating Research:

Fast HTP recombinant antibody production enables research to take place more quickly and paves the way towards clinical trials. Demand for antibodies has exponentially risen in recent years due to advancements in fields such as immuno-oncology, personalized medicine, and infectious diseases, and speed is essential to meet these growing demands efficiently.

2. Streamlining Discovery and Development Processes:

During the lead identification phase of drug discovery, rapid production allows for quick screening of large antibody libraries against targets of interest, leading to the identification of high-affinity antibodies and potential therapeutic candidates. This helps with drug development, optimizing the time required to progress from initial discovery to candidate selection.

3. Facilitating Functional and Structural Studies:

Characterization of antibody function can require high quantities of recombinant antibodies to conduct, such as determining binding affinities, epitope mapping, and characterizing antibody-mediated immune responses. Structural studies such as X-ray crystallography and cryo-electron microscopy also require purified antibodies in substantial quantities.

Biointron’s 2-week HTP recombinant antibody production is unparalled in the antibody production industry while maintaining the highest quality. At Biointron, we are dedicated to accelerating your antibody discovery, optimization, and production needs. Our team of experts can provide customized solutions that meet your specific research needs. Contact us to learn more about our services and how we can help accelerate your research and drug development projects.

Subscribe to our Blog

Recent Blog

Computational antibody methods schematic. DOI: 10.1093/bib/bbz095The development of therapeutic antibodies has been significantly enhanced by advancements in computational methods and artificial intelligence (AI). These technologies have streamlined the antibody discovery process, improving the abil

May 27, 2024
Blog

Welcometo Antibody Basics by Biointron,Part 8. In this episode, we’ll talk about therapeutics targeting cancer.What is cancer immunotherapy?Cancer immunotherapy leverages the body's immune system to fight cancer more selectively and effectively than traditional methods such as chemotherapy

May 24, 2024
Blog

The generation of an immune response to a vaccine. DOI: 10.1038/s41577-020-00479-7Vaccination is one of the most effective tools in preventing infectious diseases. At its core, the success of a vaccine hinges on its ability to induce a robust and lasting antibody response against a specific pathogen

May 22, 2024
Blog

Innovation orientation and goals for transforming CAR-T cell engineering. DOI: 10.1186/s13045-020-00910-5Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary cancer treatment in which engineered CARs redirect lymphocytes, typically T cells, to recognize and destroy cells expressing a sp

May 20, 2024
Blog

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.